Stable xenon CT in patients with chronic cerebrovascular disease.
Xenon-enhanced CT (XeCT) is a method of measuring regional cerebral blood flow (rCBF). Although it is used for acute and perioperative assessment the ability of XeCT to show hypoperfused areas in vivo, as compared with morphological imaging modalities other than noncontrast CT, is not defined. Correlation with MRI helps to define the smallest detectable hypoperfused area. We examined 17 patients 6 weeks after acute cerebral infarcts with CT, XeCT and MRI and the findings were compared. All examinations were performed with the same slice angulation and thickness and the sizes of the abnormal areas were measured. XeCT showed a high correlation with MRI, but less so with conventional CT. Lesions appeared significantly smaller on CT than on XeCT or MRI. No significant difference between MRI and XeCT changes was found. The minimal lesion on MRI correlating with a hypoperfused area on XeCT was 0.8 cm2, whereas lesions measuring less than 0.5 cm2 on MRI could not be detected on XeCT. The good correlation between XeCT and MRI underlines the reliability of rCBF examinations with XeCT. A significant difference between CT and XeCT findings shows the difficulty of interpreting hypoperfused regions only by correlation with CT. Combined XeCT and MRI gives a better estimate of the vascular state of the brain.